IPO

Trident Lifeline Limited IPO

BSE SME

Listed On: Oct 10, 2022 at ₹ 105.00

₹ 121200 /1200 Shares

Check Allotment

Trident Lifeline IPO Details

26 Sep, 2022

Open Date

29 Sep, 2022

Close Date

04 Oct, 2022

Allotment Date

10 Oct, 2022

Listing Date

Issue Price

₹101 per equity share

Face Value

₹10 Per Equity Share 

Listing at Group

BSE SME

Registrar

Link Intime India Private Ltd

List Price

105.00

Listing Date

2022-10-10

Market Lot

1200 Shares (₹121,200/-)

Lead Manager

Beeline Capital Advisors Pvt Ltd

Issue Size

3,499,200 shares of ₹10 (aggregating up to ₹35.34 Cr)

#Fresh Issue: 3,499,200 shares of ₹10 (aggregating up to ₹35.34 Cr)

Retail Portion

N/A

Subscription

1.34 times

IPO Docs

DRHP RHP

Trident Lifeline IPO Subscription Details

As onQIB / NIIRetailTotal
Shares Offered / Reserved1,662,0001,662,0003,324,000
Day 1 - 26-09-22 06:00 PM0.07 x0.06 x0.06 x
Day 2 - 27-09-22 06:00 PM0.43 x0.33 x0.38 x
Day 3 - 28-09-22 06:00 PM0.63 x0.52 x0.58 x
Day 4 - 29-09-22 06:00 PM1/40 x0.98 x1.34 x

Trident Lifeline Valuations

Earnings Per Share (EPS)

₹N/A/-

P/E Ratio

N/A

RoNW

N/A%

Net Asset Value (NAV) - Post Issue

₹N/A/-

Trident Lifeline Company Financials All values are in ₹ Lakh

30-Mar-2231-Mar-2131-Mar-20
Assets1385.981144.41638.92
Revenue2237.14978.13500.71
Profit After Tax227.3263.23-79.63

About The Company

Trident Lifeline Limited is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network.

Trident Lifeline Limited offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan licence.

Trident Lifeline product portfolio consists of 832 products, as on May 31, 2022, including Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steroidal anti-inflammatory drug (NSAIDs).

Read More

Trident Lifeline - Promoter(s)

Pre Issue Share Holding: 100%

Post Issue Share Holding: 69.57%

Company Promoter(s)

  1. Mr. Hardik Jigishkumar Desai
  2. Mr. Mayurkumar Mansukhbhai Gajera
  3. Mrs. Rupaben C Jariwala
  4. Mrs. Rinkal Mayurbhai Gajera
  5. Mr. Tarang Nathabhai Gajera
  6. Mr. Mohak Nathabhai Gajera

Trident Lifeline IPO - Issue Objectives

  1. To Meet Working Capital Requirements
  2. Product registration in the international markets
  3. General Corporate Purpose
  4. To meet Public Issue Expenses

Trident Lifeline IPO - FAQs

Ans. Trident Lifeline Limited IPO is a SME IPO. The issue is priced at ₹101 per equity share. The minimum order quantity is 1200 Shares. The IPO opens on Sep 26, 2022, and closes on Sep 29, 2022. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE SME.

Ans. The Trident Lifeline Limited IPO opens on Sep 26, 2022 and closes on Sep 29, 2022.

Ans. The size of Trident Lifeline Limited IPO is 3,499,200 shares of ₹10 (aggregating up to ₹35.34 Cr) #Fresh Issue: 3,499,200 shares of ₹10 (aggregating up to ₹35.34 Cr).

Ans. The IPO price band is set between ₹101 per equity share.

Ans. To apply for Trident Lifeline Limited IPO IPO, follow the steps given below:

  • - Open the IPO Ji App or Website
  • - Find Trident Lifeline Limited IPO in the List of IPOs
  • - Press "Apply" Button
  • - Select Your Demat Account
  • - Select Your Shares Quantity and Submit
  • - Track Your IPO Status

Ans. The share allotment date of Trident Lifeline Limited IPO is Oct 4, 2022.

Ans. The Trident Lifeline Limited IPO will be listed on Oct 10, 2022.

Ans. Follow the steps to check the allotment status for Trident Lifeline Limited IPO here.